
Primary tabs
Export 17 results:
Filters: Author is Fabienne Jurion
In-vivo expressed Mycobacterium tuberculosis antigens recognised in three mouse strains after infection and BCG vaccination.,
, NPJ Vaccines, 2021 Jun 03, Volume 6, Issue 1, (2021)
Allergic Asthma Favors Growth in the Lungs of Infected Mice.,
, Front Immunol, 2018, Volume 9, (2018)
Analysis of the vaccine potential of plasmid DNA encoding nine mycolactone polyketide synthase domains in Mycobacterium ulcerans infected mice.,
, PLoS Negl Trop Dis, 2014, Volume 8, Issue 1, p.e2604, (2014)
Increasing the Vaccine Potential of Live M. bovis BCG by Coadministration with Plasmid DNA Encoding a Tuberculosis Prototype Antigen.,
, Vaccines (Basel), 2014 Mar 05, Volume 2, Issue 1, Number 195, p.181-95, (2014)
Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis34032,
, Vaccine, 4/2/2013, Volume 31, Issue 7, Number 1064, p.1057 - 1064, (2013)
Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice1377,
, PLoS ONE, 0/0/2013, Volume 8, Issue 5, p.e63344, (2013)
Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c).,
, Vaccine, 2008 Nov 11, Volume 26, Issue 48, p.6053-63, (2008)
Immunogenicity and protective efficacy of tuberculosis DNA vaccines combining mycolyl-transferase Ag85A and phosphate transport receptor PstS-3.,
, Immunology, 2006 Jul, Volume 118, Issue 3, p.321-32, (2006)
Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.,
, Vaccine, 2006 Apr 12, Volume 24, Issue 16, p.3353-64, (2006)
Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis.,
, Infect Immun, 2003 Jan, Volume 71, Issue 1, Number 493, p.483-93, (2003)
Improved tuberculosis DNA vaccines by formulation in cationic lipids.,
, Infect Immun, 2002 Jul, Volume 70, Issue 7, Number 3688, p.3681-8, (2002)
What are the immunologically active components of bacille Calmette-Guérin in therapy of superficial bladder cancer?,
, Int J Cancer, 2000 Sep 15, Volume 87, Issue 6, (2000)
What is the optimal regimen for BCG intravesical therapy? Are six weekly instillations necessary?,
, Eur Urol, 2000 Apr, Volume 37, Issue 4, (2000)
Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection.,
, Infect Immun, 1998 Apr, Volume 66, Issue 4, p.1527-33, (1998)
Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-Group.,
, Scand J Immunol, 1997 Jul, Volume 46, Issue 1, Number 26, p.16-26, (1997)
Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette-Guérin (BCG) in patients with superficial bladder cancer.,
, Clin Exp Immunol, 1997 Jul, Volume 109, Issue 1, (1997)
Mapping of TH1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG36652,
, Infect.Immun., 0/2/1994, Volume 62, Issue 2, Number 370, p.363 - 370, (1994)